灵芝生物活性及产业标准化现状:综合评述。
Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review.
发表日期:2024 Oct 15
作者:
Peng Wu, Chengyun Zhang, Yueyue Yin, Xiaobin Zhang, Qi Li, Lijingyi Yuan, Yahe Sun, Shuhua Zhou, Shanting Ying, Jiayan Wu
来源:
ANTIOXIDANTS & REDOX SIGNALING
摘要:
灵芝 (GL) 是生物活性化合物的有效来源,具有多种营养和药理功效。它作为膳食补充剂、草药和健康产品的受欢迎程度正在稳步上升。此外,GL行业的标准化进步促进了原材料的可靠采购和质量控制措施,增强了其在营养科学和药物研究领域的利用和认可。本文全面概述了 GL 生物活性成分,特别是多糖 (GLP) 和三萜 (GLT) 的最新研究进展,并重点介绍了它们对人类疾病有益作用的最新发现,包括抗癌、抗糖尿病、肝脏保护等方面(如调节肠道菌群、抗氧化、抗菌、抗炎和免疫调节)。此外,我们还总结了GL在食品和医药领域的潜在应用,同时也审视了国内外GL全产业链的标准化现状。这些信息为工业发展前景和 GL 在全球健康行业的创新进步提供了见解和指导。© 2024 作者。
Ganoderma lucidum (GL) is a potent source of bioactive compounds with diverse nutritional and pharmacological benefits. Its popularity as a dietary supplement, herbal remedy, and wellness product is steadily on the rise. Furthermore, the standardized advancement of the GL industry has facilitated reliable sourcing of raw materials and quality control measures, enhancing its utilization and endorsement in the realms of nutritional science and pharmaceutical research. This article provides a comprehensive overview of the recent advancements in research pertaining to the bioactive components of GL, particularly polysaccharides (GLP) and triterpenes (GLTs) as well as highlights the latest findings regarding their beneficial effects on human diseases, including anticancer, antidiabetes, liver protection and other aspects (such as regulating gut microbiota, antioxidant, antimicrobial, antiinflammatory and immune regulation). Furthermore, we summarized the potential applications of GL in the food and pharmaceutical sectors, while also examining the current status of standardization throughout the entire industrial chain of GL, both domestically and internationally. These information offer an insight and guidance for the prospects of industrial development and the innovative advancement of GL within the global health industry.© 2024 The Authors.